|
WO2000075327A1
(fr)
*
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methodes et compositions d'inhibition de croissance cellulaire neoplasique
|
|
JP2001522239A
(ja)
|
1997-03-21 |
2001-11-13 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
８７個のヒト分泌タンパク質
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020127576A1
(en)
*
|
1997-06-16 |
2002-09-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7160985B2
(en)
*
|
1997-10-29 |
2007-01-09 |
Genentech, Inc. |
Pro180 polypeptide
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7425613B2
(en)
|
1997-11-05 |
2008-09-16 |
Genentech, Inc. |
PRO1375 polypeptides
|
|
US6949339B1
(en)
|
1998-05-21 |
2005-09-27 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging colon cancer
|
|
US7160679B1
(en)
|
1998-05-21 |
2007-01-09 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging lung cancer
|
|
US6623923B1
(en)
|
1998-12-23 |
2003-09-23 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US6914130B2
(en)
|
1998-06-17 |
2005-07-05 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20030065154A1
(en)
|
2000-03-30 |
2003-04-03 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
|
US20020172678A1
(en)
*
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
|
US7507557B2
(en)
|
1998-08-17 |
2009-03-24 |
Genentech, Inc. |
Nucleic acids encoding PRO1375 polypeptides
|
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP1109937B1
(fr)
|
1998-09-02 |
2008-11-05 |
Diadexus, Inc. |
PROCEDE DE DIAGNOSTIC, DE SURVEILLANCE, DE CLASSIFICATION PAR STADES et D'IMAGERIE DE DIVERS CANCERS
|
|
AU5447899A
(en)
*
|
1998-09-03 |
2000-03-27 |
Takeda Chemical Industries Ltd. |
Novel protein and process for producing the same
|
|
US7014996B1
(en)
|
1998-10-02 |
2006-03-21 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
|
|
ATE351905T1
(de)
|
1998-11-10 |
2007-02-15 |
Univ Emory |
Mitogene regulatoren
|
|
US6670463B1
(en)
|
1998-12-17 |
2003-12-30 |
Corixa Corporation |
Compositions and methods for therapy of ovarian cancer
|
|
US20020119158A1
(en)
*
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6962980B2
(en)
*
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6468546B1
(en)
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
AU2007216683B2
(en)
*
|
1998-12-17 |
2011-07-14 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US7888477B2
(en)
|
1998-12-17 |
2011-02-15 |
Corixa Corporation |
Ovarian cancer-associated antibodies and kits
|
|
EP1767636A3
(fr)
*
|
1998-12-23 |
2007-06-13 |
Corixa Corporation |
Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation
|
|
US6284241B1
(en)
|
1998-12-23 |
2001-09-04 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US20030009013A1
(en)
*
|
1998-12-30 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
PL350339A1
(en)
*
|
1999-03-15 |
2002-12-02 |
Takeda Chemical Industries Ltd |
Novel proteins and uses thereof
|
|
US6242419B1
(en)
*
|
1999-03-25 |
2001-06-05 |
Genesis Research & Development Corporation Ltd. |
Compositions isolated from stromal cells and methods for their use
|
|
US6797271B2
(en)
|
1999-03-25 |
2004-09-28 |
Genesis Research & Development Corporation Limited |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
|
|
AU782985B2
(en)
*
|
1999-04-09 |
2005-09-15 |
Curagen Corporation |
Novel human proteins and polynucleotides encoding them
|
|
EP1792989A1
(fr)
*
|
1999-04-12 |
2007-06-06 |
Agensys, Inc. |
Protéine à treize segments transmembranaires exprimée dans le cancer de la prostate
|
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
|
EP2365081A3
(fr)
*
|
1999-04-12 |
2012-07-18 |
Agensys, Inc. |
Protéine à treize segments transmembranaires exprimée dans le cancer de la prostate
|
|
US7244827B2
(en)
|
2000-04-12 |
2007-07-17 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
|
|
JP2003524402A
(ja)
*
|
1999-05-14 |
2003-08-19 |
キュラジェン コーポレイション |
新規のポリヌクレオチドおよびそれによりコードされるポリペプチド
|
|
EP1179540A4
(fr)
*
|
1999-05-20 |
2002-10-09 |
Takeda Chemical Industries Ltd |
Nouveau polypeptide
|
|
AU5037100A
(en)
*
|
1999-05-27 |
2000-12-18 |
Zymogenetics Inc. |
Adipocyte complement related protein homolog zacrp6
|
|
CA2383254A1
(fr)
*
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Polypeptides transmembranaires secretes et acides nucleiques codants pour ceux-ci
|
|
IL147652A0
(en)
*
|
1999-07-23 |
2002-08-14 |
Kangawa Kenji |
Novel peptides
|
|
WO2001009321A1
(fr)
*
|
1999-07-29 |
2001-02-08 |
Helix Research Institute |
Gene codant pour une nouvelle proteine de type tsp1
|
|
CA2381396A1
(fr)
*
|
1999-08-11 |
2001-02-15 |
Curagen Corporation |
Polynucleotides et polypeptides codes par ces derniers
|
|
AU6916100A
(en)
*
|
1999-08-18 |
2001-03-13 |
Zymogenetics Inc. |
Helical cytokine zalpha48
|
|
EP1623993A3
(fr)
*
|
1999-09-01 |
2006-06-07 |
Genetech, Inc. |
Protéines sécrétées et transmembranaire et acides nucléiques les codant
|
|
EP1208202A2
(fr)
*
|
1999-09-01 |
2002-05-29 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
|
|
CA2384749A1
(fr)
*
|
1999-09-13 |
2001-03-22 |
Curagen Corporation |
Nouvelles proteines humaines, polynucleotides codant celles-ci et procedes d'utilisation des memes
|
|
WO2001023553A2
(fr)
*
|
1999-09-29 |
2001-04-05 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
C4.4a, un nouvel antigène associée à la métastase
|
|
DE19947010A1
(de)
*
|
1999-09-30 |
2001-04-05 |
Universitaetsklinikum Freiburg |
Das Gen PRV-1 und dessen Verwendung
|
|
GB9926532D0
(en)
*
|
1999-11-09 |
2000-01-12 |
Smithkline Beecham Biolog |
Novel compounds
|
|
WO2001034804A1
(fr)
*
|
1999-11-12 |
2001-05-17 |
Lexicon Genetics Incorporated |
Proteines membranaires humaines et polynucleotides codant pour elles
|
|
US6485938B1
(en)
|
1999-11-16 |
2002-11-26 |
Zymogenetics, Inc. |
Nucleic acid molecules that encodes human Zven1
|
|
AU1608201A
(en)
*
|
1999-11-16 |
2001-05-30 |
Zymogenetics Inc. |
Human zven proteins
|
|
WO2001042466A2
(fr)
*
|
1999-12-09 |
2001-06-14 |
Zymogenetics, Inc. |
Zvwf1: un membre de la superfamille caracterisee par le domaine de type a du facteur willebrand
|
|
AU2575601A
(en)
*
|
1999-12-10 |
2001-06-18 |
Incyte Genomics, Inc. |
Extracellular matrix and cell adhesion molecules
|
|
EP1242598A2
(fr)
*
|
1999-12-30 |
2002-09-25 |
Corixa Corporation |
Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation
|
|
EP1244784A2
(fr)
*
|
2000-01-06 |
2002-10-02 |
Genentech, Inc. |
Methodes et compositions permettant d'inhiber la croissance cellulaire neoplasique
|
|
EP1252298A2
(fr)
*
|
2000-01-28 |
2002-10-30 |
Incyte Genomics, Inc. |
Phosphodiesterases
|
|
AU2001245371A1
(en)
|
2000-02-28 |
2001-09-12 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
|
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020016449A1
(en)
*
|
2000-03-24 |
2002-02-07 |
Meyers Rachel A. |
46743 and 27417, novel human acyltransferase family members and uses therefor
|
|
CA2403572A1
(fr)
*
|
2000-03-22 |
2001-09-27 |
Amgen Inc. |
Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
|
|
DE60126602T2
(de)
*
|
2000-04-21 |
2007-11-22 |
Fuso Pharmaceutical Industries, Ltd. |
Neue collectine
|
|
JP2007274956A
(ja)
*
|
2006-04-05 |
2007-10-25 |
Fuso Pharmaceutical Industries Ltd |
コレクチン活性を有するｈＣＬ−Ｋ１ポリペプチド
|
|
EP1278869A2
(fr)
*
|
2000-05-04 |
2003-01-29 |
Incyte Genomics, Inc. |
Proteases
|
|
US6444443B1
(en)
*
|
2000-05-19 |
2002-09-03 |
Novartis Ag |
Gene
|
|
CA2411667A1
(fr)
|
2000-05-30 |
2001-12-06 |
Merck & Co. Inc. |
Analogues de la ghreline
|
|
KR100961345B1
(ko)
*
|
2000-06-23 |
2010-06-04 |
제넨테크, 인크. |
Ｅｇ-ｖｅｇｆ 핵산 및 폴리펩티드 및 사용 방법
|
|
US20020165347A1
(en)
*
|
2000-06-30 |
2002-11-07 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
|
WO2002006483A1
(fr)
*
|
2000-07-18 |
2002-01-24 |
Takeda Chemical Industries, Ltd. |
Nouveau peptide actif sur le plan physiologique et utilisation associee
|
|
JP4965776B2
(ja)
*
|
2000-07-18 |
2012-07-04 |
武田薬品工業株式会社 |
新規生理活性ペプチドおよびその用途
|
|
US6891030B2
(en)
|
2000-07-27 |
2005-05-10 |
Mayo Foundation For Medical Education And Research |
T-cell immunoregulatory molecule
|
|
EP1311662A2
(fr)
*
|
2000-08-24 |
2003-05-21 |
Genentech, Inc. |
Compositions et methodes pour le diagnostic et le traitement de tumeurs
|
|
CA2421056A1
(fr)
*
|
2000-09-01 |
2002-03-28 |
Genentech, Inc. |
Polypeptide servant de marqueur diagnostique de presence de tumeurs du colon
|
|
US20020177696A1
(en)
*
|
2000-10-30 |
2002-11-28 |
Yongming Sun |
Compositions and methods relating to breast specific genes and proteins
|
|
AU2002230778A1
(en)
*
|
2000-11-03 |
2002-05-15 |
The Regents Of The University Of California |
Prokineticin polypeptides, related compositions and methods
|
|
EP1506971A1
(fr)
*
|
2000-11-03 |
2005-02-16 |
The Regents of the University of California |
Polypeptides prokinéticines; compositions et méthodes apparentées
|
|
WO2002052019A2
(fr)
*
|
2000-12-21 |
2002-07-04 |
Millennium Pharmaceuticals, Inc. |
22437, nouvelle sulfatase humaine et utilisations correspondantes
|
|
US20060063230A1
(en)
|
2000-12-27 |
2006-03-23 |
Roman Naworth |
Sulfatases and methods of use thereof
|
|
US20040072293A1
(en)
*
|
2001-02-02 |
2004-04-15 |
Tetsuya Ohtaki |
Novel physiologically active peptide and use thereof
|
|
US20020115136A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
EP1873245A1
(fr)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Polypeptides homologue à l'interleukine-8 et utilisations thérapeutiques correspondantes
|
|
WO2002077229A2
(fr)
*
|
2001-03-01 |
2002-10-03 |
Lion Bioscience Ag |
Nouveaux cofacteurs du recepteur alpha x du foie et techniques d'utilisation
|
|
EP2280030A3
(fr)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers
|
|
AU2008201044B2
(en)
*
|
2001-04-10 |
2011-07-28 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
PL370105A1
(en)
|
2001-05-25 |
2005-05-16 |
Amgen, Inc. |
B7 related protein-2 molecules and uses thereof
|
|
WO2003002737A1
(fr)
*
|
2001-06-27 |
2003-01-09 |
Riken |
Nouvelle proteine inhibitrice de la topoisomerase humaine 2$g(a) et utilisation associee
|
|
CA2453653A1
(fr)
*
|
2001-07-26 |
2003-02-06 |
Genset S.A. |
Polynucleotides et polypeptides gmg-2 et leurs utilisations
|
|
US7888478B2
(en)
|
2002-09-11 |
2011-02-15 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
US7858330B2
(en)
|
2001-10-19 |
2010-12-28 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
US20040197778A1
(en)
*
|
2002-12-26 |
2004-10-07 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
|
US20030018172A1
(en)
*
|
2001-12-06 |
2003-01-23 |
Genentech, Inc. |
Secreted transmembrane polypeptides and nucleic acids encoding the same
|
|
US7557196B2
(en)
*
|
2001-12-07 |
2009-07-07 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
hGC-1, a gene encoding a member of the olfactomedin-related protein family
|
|
US7041499B2
(en)
*
|
2001-12-12 |
2006-05-09 |
University Of North Texas Health Science Center |
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
|
|
DE60324797D1
(de)
*
|
2002-05-31 |
2009-01-02 |
Seikagaku Kogyo Co Ltd |
Chondroitinsynthetase und das enzym codierende dna
|
|
JP2006516090A
(ja)
|
2002-10-04 |
2006-06-22 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
神経発生に関連するスクリーニング方法および治療方法
|
|
US7205110B2
(en)
|
2002-10-07 |
2007-04-17 |
Zymogenetics, Inc. |
Uses of human Zven antagonists
|
|
EP1579218A2
(fr)
|
2002-12-20 |
2005-09-28 |
Enkam Pharmaceuticals A/S |
Methode de modulation de l'interaction d'un recepteur et d'un ligand
|
|
WO2004078969A1
(fr)
*
|
2003-03-06 |
2004-09-16 |
The New Industry Research Organization |
Identification et utilisation du facteur de polymerisation de la chondroitine
|
|
JP4912144B2
(ja)
|
2003-03-12 |
2012-04-11 |
ジェネンテック， インコーポレイテッド |
造血促進のためのｂｖ８及び／又はｅｇ−ｖｅｇｆの使用
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
JP4884224B2
(ja)
*
|
2003-05-09 |
2012-02-29 |
ディアデクサス インコーポレーテッド |
Ｏｖｒ１１０抗体組成物および使用方法
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
DE602006013275D1
(de)
|
2005-01-07 |
2010-05-12 |
Diadexus Inc |
Ovr110-antikörperzusammensetzungen und verwendungsverfahren dafür
|
|
EP3058955B1
(fr)
|
2005-03-24 |
2019-05-29 |
Millennium Pharmaceuticals, Inc. |
Anticorps se liant à l'ov064 et leurs procédés d'utilisation
|
|
BRPI0620601A2
(pt)
|
2005-12-08 |
2011-11-16 |
Medarex Inc |
anticorpo monoclonal humano isolado ou uma porção ligante ao antìgeno do mesmo, composição, imunoconjugado, molécula de ácido nucléico isolada, vetor de expressão, célula hospedeira, método para preparar um anticorpo anti-o8e e método para tratar ou prevenir uma doença definida pelo crescimento de células tumorais expressando o8e
|
|
WO2008067283A2
(fr)
|
2006-11-27 |
2008-06-05 |
Diadexus, Inc. |
Compositions d'anticorps ovr110 et leurs procédés d'utilisation
|
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
|
EP2124998B8
(fr)
|
2006-12-27 |
2015-05-06 |
The Johns Hopkins University |
Procédés pour la detection d'inflammations et de maladies auto-immunes
|
|
EP2385114A4
(fr)
|
2008-12-25 |
2012-08-08 |
Univ Tokyo |
Diagnostic de traitement d'un cancer à l'aide d'un anticorps anti-tm4sf20
|
|
EP2473523A2
(fr)
|
2009-08-31 |
2012-07-11 |
Amplimmune, Inc. |
Méthodes et compositions permettant d'inhiber les rejets de greffe
|
|
EP3383908A1
(fr)
|
2015-12-02 |
2018-10-10 |
Stsciences, Inc. |
Anticorps spécifiques au btla glycosylé (atténuateur de lymphocytes b et t)
|
|
CN113214377B
(zh)
*
|
2020-01-21 |
2022-10-28 |
四川大学 |
一种抗菌肽ap-64及其制备方法和用途
|